Canada markets closed

Acticor Biotech SAS (7V7.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
3.40000.0000 (0.00%)
At close: 08:59AM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
Operating Expenses
Research Development
11,479
10,761
8,398
5,481
Selling General and Administrative
3,367
3,569
3,526
1,600
Total Operating Expenses
16,655
15,102
11,831
7,562
Operating Income or Loss
-16,655
-15,102
-11,831
-7,562
Interest Expense
2,460
766
721
0
Income Before Tax
-18,649
-15,878
-12,608
-7,651
Income Tax Expense
0
0
0
0
Income from Continuing Operations
-18,649
-15,878
-12,608
-7,651
Net Income
-18,649
-15,878
-12,608
-7,651
Net Income available to common shareholders
-18,649
-15,878
-12,608
-7,651
Basic EPS
-1.67
-1.49
-1.62
-0.73
Diluted EPS
-1.67
-1.49
-1.62
-0.73
Basic Average Shares
11,089
10,546
7,780
10,546
Diluted Average Shares
11,089
10,546
7,780
10,546